The expanded indication includes conduction system pacing (CSP) and sensing of the left bundle branch area (LBBA) when the pacing leads — thin wires placed inside the heart and connected to an implantable device — are connected to a single- or dual-chamber pacemaker. This news follows Biotronik’s expanded labeling for left bundle branch area pacing announced yesterday.

Pacing of the LBBA offers an alternative to traditional right ventricular pacing for treating symptomatic bradycardia. Through this approach, which uses the heart’s natural electrical system, a lead goes into the LBBA of the heart’s conduction system. This may promote greater ventricular synchrony and reduce the long-term risk of heart failure associated with traditional right ventricular pacing, according to a news release.